Association of tumour necrosis factor-alpha -308 G/A polymorphism with primary open-angle glaucoma

Clinical and Experimental Ophthalmology

Volumn 40, Issue 4, 2012, Pages

  Bozkurt, Banu ^a   Mesci, Lutfiye ^b   Irkec, Murat ^b   Ozdag, Burcin B ^c   Sanal, Ozden ^b   Arslan, Umut ^b   Ersoy, Fugen ^b   Tezcan, Ilhan ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c GÜVEN HOSPITAL   (Turkey)

Author keywords

Direct gene sequencing; Primary open angle glaucoma; TNF alpha 238 G A polymorphism; TNF alpha 308 G A polymorphism; Turkish population

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; OPHTHALMOSCOPY; PROMOTER REGION; PROSPECTIVE STUDY; SLIT LAMP; VISUAL ACUITY;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; SEQUENCE ANALYSIS, DNA; TUMOR NECROSIS FACTOR-ALPHA; TURKEY;

EID: 84862526069     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2011.02595.x     Document Type: Article

References (35)

1. Sommer A, Tielsch JM, Katz J etal. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch Ophthalmol 1991; 109: 1090-5.
2. Le A, Mukesh BN, McCarty CA, Taylor HR. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci 2003; 44: 3783-9.
3. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1268-79.
4. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 1995; 61: 33-44.
5. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 1997; 115: 1031-5.
6. Farkas RH, Grosskreutz CL. Apoptosis, neuroprotection and retinal ganglion cell death: an overview. Int Ophthalmol Clin 2001; 41: 111-30.
7. Mittag TW, Danias J, Pohorenec G etal. Retinal damage after 3 to 4months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci 2000; 41: 3451-9.
8. Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Corderio MF. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci 2005; 46: 175-82.
9. Schwartz M, Belkin M, Yoles E, Solomon A. Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neurodegeneration. J Glaucoma 1996; 5: 427-32.
10. Shetty V, Mundle S, Alvi S etal. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res 1996; 20: 891-900.
11. Gersuk GR, Beckham C, Loken MR etal. A role for tumour necrosis factor-α Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 1998; 103: 176-88.
12. Tezel G, Li LY, Patil RV, Wax MB. TNF- α and TNF- α receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 2001; 42: 1787-94.
13. Yan X, Tezel G, Wax WB, Edward DP. Matrix metalloproteinases and tumor necrosis factor-α in glaucomatous optic nerve head. Arch Ophthalmol 2000; 118: 666-73.
14. Tezel G, Wax MB. Increased production of tumor necrosis factor- α by glial cells exposed to stimulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 2000; 20: 8693-700.
15. Yuan L, Neufeld AH. Tumor necrosis factor- alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2000; 32: 42-50.
16. Wax MB, Tezel G. Neurobiology of glaucomatous optic neuropathy. Mol Neurobiol 2002; 26: 45-55.
17. Nakazawa T, Nakazawa C, Matsubara A etal. Tumor necrosis factor- α mediates oligodentrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 2006; 26: 12633-41.
18. Hajeer AH, Hutchinson IV. Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Hum Immunol 2001; 62: 1191-9.
19. Jongeneel CV, Briant L, Udalova IA, Sevin A, Nedospasov SA, Cambon-Thomsen A. Extensive genetic polymorphism in the human TNF region and relation to extended HLA haplotype. Proc Natl Acad Sci USA 1991; 88: 9717-21.
20. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 1999; 66: 562-6.
21. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activity. Proc Natl Acad Sci USA 1997; 94: 3195-9.
22. Bouma G, Crusius JB, Oudkerk Pool M etal. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996; 43: 456-63.
23. Louis E, Franchimont D, Piron A etal. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-6.
24. Fong CW, Siddiqui AH, Mark DF. Identification and characterization of a novel repressor site in the human tumor necrosis factor a gene. Nucleic Acids Res 1994; 22: 1108-14.
25. Lin HJ, Tsai FJ, Chen WC, Shi YR, Hsu Y, Tsai SW. Association of tumor necrosis factor alpha-308 gene polymorphism with primary open-angle glaucoma in Chinese. Eye 2003; 17: 31-4.
26. Khan MI, Micheal S, Rana N, Akhtar F, den Hollander AI, Ahmed A, Qamar R. Association of tumor necrosis factor alpha gene polymorphism G-308A with pseudoexfoliative glaucoma in the Pakistani population. Mol Vis 2009; 15: 2861-7.
27. Razeghinejad MR, Rahat F, Kamali-Sarvestani E. Association of TNFA -308 G/A and TNFRI +36 A/G gene polymorphisms with glaucoma. Ophthalmic Res 2009; 42: 118-24.
28. Mossböck G, Weger M, Moray M etal. TNF-alpha promoter polymorphisms and primary open-angle glaucoma. Eye 2006; 20: 1040-3.
29. Tekeli O, Turacli ME, Egin Y, Akar N, Elhan AH. Tumor necrosis factor alpha-308 gene polymorphism and pseudoexfoliation glaucoma. Mol Vis 2008; 14: 1815-18.
30. Mossböck G, Renner W, El-Shabrawi Y etal. TNF-alpha -308 G>A and -238 G>A polymorphisms are not major risk factors in Caucasian patients with exfoliation glaucoma. Mol Vis 2009; 15: 518-22.
31. Tezel G. TNF-alpha signaling in glaucomatous neurodegeneration. Prog Brain Res 2008; 173: 409-21.
32. Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by NMethyl- d-aspartate receptor activation: essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinasedependent NF-kappa B pathway. J Biol Chem 2004; 279: 32869-81.
33. Funayama T, Ishikawa K, Ohtake Y etal. Variants in optineurin gene and their associations with tumor necrosis factor-alpha polymorphisms in Japanese patients with glaucoma. Invest Ophthalmol Vis Sci 2004; 45: 4359-67.
34. Freimer N, Sabatti C. The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. Nat Genet 2004; 36: 1045-51.
35. Reynard MP, Turner D, Navarrete CV. Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet 2000; 27: 241-9.